FDA Panel Rejects Pimavanserin for Alzheimer's Psychosis
An FDA advisory panel has rejected the atypical antipsychotic pimavanserin for the treatment of Alzheimer’s disease psychosis.
Source: medscape.com
Walters Dunn News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Walters Dunn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Walters Dunn Today - Breaking & Trending Today
FDA Advisers Reject Nuplazid for Alzheimer's Disease Psychosis
Weak trial data not enough to persuade panel to recommend approval
Source: medpagetoday.com
Prader-Willi Syndrome Drug Receives a Resounding 'No' from FDA Advisory Panel
An FDA advisory panel has voted overwhelmingly against a new drug application for intranasal carbetocin, intended to treat symptoms associated with Prader-Willi Syndrome.
Source: medscape.com